Lonely At The Top? Not In OTC Sector As Bayer, GSK/Novartis Challenge J&J
This article was originally published in The Tan Sheet
Bayer closes its acquisition of Merck & Co.’s consumer business, aiming to become the top OTC player and saying other consumer product acquisitions could follow. Glaxo and Novartis look to close their agreement to combine their OTC businesses in the first half of 2015.